Spirea - Crunchbase Company Profile & Funding

Q: Who invested in Spirea?

Spirea has 11 investors including SyndicateRoom And O2h Ventures.

Q: When was the last funding round for Spirea?

Spirea closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Spirea

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Spirea

CB Rank

124804

Spirea Ltd. operates as a healthcare technology company.

Founded

obfuscation

Private

Venture - Series Unknown

Cambridge, Cambridgeshire, United Kingdom

1-10

www.spirea.co.uk/

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

Spirea Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.

Predictions & Insights

Growth Insight

See this Growth Insight

Spirea is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

hiDAR ADC Linker Platform Technology

A platform technology enabling the creation of antibody drug conjugates with high and stable drug-to-antibody ratios and diverse payload incorporation.

Antibody Drug Conjugate Therapeutic Programmes

Development of targeted cancer therapies using antibody drug conjugates that deliver cytotoxic drugs to tumor cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spirea	7	obfuscated obfuscation	Jonathan Milner, University of Cambridge Enterprise	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SyndicateRoom	—	Venture Round - Spirea	—
SyndicateRoom	—	Venture Round - Spirea	—
SyndicateRoom	—	Venture Round - Spirea	—
SyndicateRoom	—	Venture Round - Spirea	—
SyndicateRoom	—	Venture Round - Spirea	—